Denmark has suspended use of AstraZeneca’s COVID-19 vaccine after some people who got the jab later developed blood clots. The country’s health agency said there was currently no evidence that the vaccine was behind the blood clots, but suspended its use as a precautionary measure because it was investigating the matter further.
“At the moment it cannot be concluded whether there is a link between the vaccine and the blood clots,” the Danish health authority said in a statement, pointing out that it had decided to stop using the jab suspend, “based on a precautionary principle” that one person who received a blood clot after vaccination died.
In a release provided to Fox News, the European Medicines Agency said it was aware that the country was interrupting the use of the jab, but noted that it could still be administered as the blood clot investigation continued.
“There is currently no indication that vaccination has caused these conditions, which are not listed as side effects with this vaccine,” the regulator said. “The safety committee of the EMA, PRAC, is of the opinion that the benefits of the vaccine still outweigh the risks and that the vaccine can still be administered while investigating cases of thromboembolic events.”
CORONAVIRUS DECLARES ONE YEAR GENERAL PANDEMY: ‘TOGETHER, WE WILL FOLLOW UP’
The EMA also noted in its release that the number of thromboembolic events in vaccinated people “is not higher than the number seen in the general population.”
“On March 10, 2021, 30 cases of thromboembolic events were reported among nearly 5 million people vaccinated with the COVID-19 vaccine AstraZeneca in the European Economic Area,” he said.
Some experts have also pointed out that of the millions of AstraZeneca vaccine shots administered elsewhere, including in Britain, no cases of the vaccine causing blood clots or related problems have been reported. Others have noted that vaccination disruption at a time when the world is still struggling to control the new coronavirus is risky, as vaccination vaccination could carry a greater risk of contracting COVID-19 and possibly dying.
The UK medical regulator responded by noting that there was no confirmation that the reported blood clot was caused by the AstraZeneca vaccine.
LEARNED TO ADDRESS THE PEOPLE ON JUBILEE OF COVID-19 PANDEMY
“People still have to fetch their COVID-19 vaccine when asked to do so,” it says.
However, following the Danish announcement, Norway decided to follow suit and temporarily suspend the vaccine from the Anglo-Swedish company, which was developed by the University of Oxford, and also said that there were no proven links. In addition, the pharmaceutical agency of Italy on Thursday ordered a preventive ban on a specific group of AstraZeneca vaccine following ‘serious adverse events’.
On Wednesday, the EMA said Austria suspended the use of a quantity of COVID-19 vaccine made by AstraZeneca after a person diagnosed with multiple blood clots died 10 days after vaccination. be vaccinated. The latter is recovering now.
The EMA received two other reports of similar problems for this group on March 9, although there is no indication that the problems were caused by the vaccine.
The EMA said that the group concerned had delivered 1 million doses to 17 EU countries.
CLICK HERE FOR FULL CORONAVIRUS COVERAGE
The German Paul Ehrlich Institute, which oversees vaccine issues, said it was in contact with the Danish authorities and the EMA, but that there were no doses of the group used in Austria on the German market.
The suspension of Denmark for the AstraZeneca vaccine will take Denmark at least two weeks, the agency said.
A AstraZeneca spokesman did not immediately return Fox News’ request for comment.
The Associated Press contributed to this report.